diabetes prevention

Differential Physical Activity Responses to Diabetes Risk Reduction Interventions According to Prediabetes Phenotype: Insights from Pooled Randomized Controlled Trials

By MedXY 09/16/2026

The effectiveness of lifestyle interventions promoting physical activity for diabetes risk reduction varies by prediabetes phenotype, with individuals having impaired fasting glucose showing the least response. Tailored approaches may enhance prevention outcomes.

Cardiology Diabetes & Endocrinology news

Early Weight Loss in Impaired Glucose Tolerance Significantly Lowers Long-term Cardiovascular and Mortality Risks: Insights from the Da Qing Diabetes Prevention Study

By MedXY 08/24/2026

Early weight loss after impaired glucose tolerance diagnosis is linked to markedly reduced long-term risk of cardiovascular events and death, underscoring the importance of early lifestyle interventions in prediabetes management.

Diabetes & Endocrinology news Public Health

Staging Intermediate Hyperglycaemia to Improve Type 2 Diabetes Prevention: Findings from the ELSA-Brasil Study

By MedXY 05/13/2026

The ELSA-Brasil study found that staging intermediate hyperglycaemia with fasting glucose plus 1-hour glucose better predicted type 2 diabetes than fasting glucose plus HbA1c, and a clinical risk score reduced unnecessary testing.

Diabetes & Endocrinology Internal Medicine news

Beyond the High-Protein Hype: Why Moderate Diets May Be the Secret to Reversing Prediabetes

By MedXY 01/10/2026

A major long-term trial reveals that a moderate-protein, moderate-glycaemic index diet is more effective for sustaining prediabetes remission than high-protein alternatives, regardless of total weight loss.

Diabetes & Endocrinology news

Prediabetes Remission Without Weight Loss: Rethinking Targets to Prevent Type 2 Diabetes

By MedXY 11/12/2025

A post hoc analysis of PLIS and replication in the DPP show that achieving prediabetes remission—normalization of glucose—can prevent type 2 diabetes even without net weight loss, via improved insulin sensitivity, β‑cell function and favorable adipose redistribution.

Clinical Updates Diabetes & Endocrinology news Superintelligence

Evaluating AI-Led vs Human-Led Lifestyle Interventions in Prediabetes: Evidence from a Randomized Clinical Trial of the Diabetes Prevention Program

By MedXY 10/29/2025

This review examines the first phase 3 randomized trial demonstrating that an AI-powered Diabetes Prevention Program lifestyle intervention is noninferior to human coaching in improving weight loss, HbA1c, and physical activity among adults with prediabetes and overweight or obesity.